ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in LLY — ELI LILLY & Co

CIK 1164508 BOSTON, MA

Back to LLY Full portfolio

Position in LLY

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$260,109,116

+$79,921,803 QoQ

Shares Held

282,798

+68.7% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

24 quarters on record

Voting authority Sole 71.05814043946562.ToString("F0")% Shared 0.ToString("F0")% None 28.941859560534372.ToString("F0")%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,760,772,587 across 11 Drug Manufacturers - General names. LLY ranks #5 (9.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	4,652,246	$917,515,956
2	BMY	Bristol Myers Squibb Co	8,872,779	$538,134,046
3	MRK	Merck & Co., Inc.	2,936,330	$353,211,135
4	NVO	Novo Nordisk A S	7,827,491	$287,660,294
5	LLY	ELI LILLY & Co This page	282,798	$260,109,116
6	JNJ	Johnson & Johnson	1,004,689	$245,586,179
7	GSK	GSK plc	1,621,397	$89,484,900
8	ABBV	AbbVie Inc.	122,181	$26,573,145

All Filings in LLY

Export CSV

24 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$260,109,116	282,798	+68.7%	Shares	Defined	2026-05-14
2025-12-31	$180,187,313	167,666	+67.0%	Shares	Defined	2026-02-13
2025-09-30	$76,607,489	100,403	+142.5%	Shares	Defined	2025-11-13
2025-03-31	$34,198,455	41,407	+178.9%	Shares	Defined	2025-05-14
2024-12-31	$11,462,656	14,848	-99.1%	Shares	Defined	2025-02-12
2024-09-30	$1,443,323,835	1,629,144	+1.3%	Shares	Defined	2024-11-14
2024-06-30	$1,456,490,238	1,608,706	+37.6%	Shares	Defined	2024-08-14
2024-03-31	$909,377,670	1,168,926	+24.4%	Shares	Defined	2024-05-15
2023-12-31	$547,753,019	939,671	-36.1%	Shares	Defined	2024-02-14
2023-09-30	$790,468,438	1,471,652	+6.5%	Shares	Defined	2023-11-14
2023-06-30	$647,887,897	1,381,483	-4.5%	Shares	Defined	2023-08-14
2023-03-31	$496,987,464	1,447,171	-25.1%	Shares	Defined	2023-05-15
2022-12-31	$707,247,741	1,933,216	-22.1%	Shares	Defined	2023-02-14
2022-09-30	$802,810,469	2,482,791	-30.4%	Shares	Defined	2022-11-14
2022-06-30	$1,157,115,590	3,568,811	+7.8%	Shares	Defined	2022-08-15
2022-03-31	$948,375,251	3,311,713	+54.8%	Shares	Defined	2022-05-13
2021-12-31	$590,892,309	2,139,209	+102.9%	Shares	Defined	2022-02-14
2021-09-30	$243,637,372	1,054,479	+1509.0%	Shares	Defined	2021-11-12
2021-06-30	$15,041,593	65,535	-84.0%	Shares	Defined	2021-08-13
2021-03-31	$76,746,963	410,807	-51.2%	Shares	Defined	2021-05-14
2020-12-31	$142,254,791	842,542	-32.2%	Shares	Defined	2021-02-12
2020-09-30	$184,056,801	1,243,459	+38.2%	Shares	Defined	2020-11-12
2020-06-30	$147,744,432	899,893	+297.4%	Shares	Defined	2020-08-12
2020-03-31	$31,415,363	226,466	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.